ARTV   $6.96  -9.14% Market Closed

Artiva Biotherapeutics Inc
Total Cash 46.56M
totalCashPerShare 1.917
EBITDA -29.50M
Total Debt 15.77M
quickRatio 4.444
currentRatio 4.595
Total Revenue 29.26M
debtToEquity 62.273
Revenue/Share 36.149
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -50.19M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins -1.0083699
operatingMargins -1.08836
profitMargins -1.11174
enterpriseValue 445.98M
forwardPE -3.1072464
floatShares 4.02M
sharesOutstanding 24.29M
sharesShort 940.52K
sharesShortPriorMonth 66.41K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.21%
heldPercentInstitutions 0.75%
Short Ratio help_outline 3.53%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue -234.705
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -32.52M
trailingEps -0.93%
forwardEps -3.45%
enterpriseToEbitda -15.12
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.91 3Q 2024
institutionsCount 14
lastUpdated Nov. 2, 2024, 7:52 a.m.